✦ LIBER ✦

Pharmacokinetics of anti-ganglioside GD2 mAb 14G2a in a phase I trial in pediatric cancer patients

✍ Scribed by Martina M. Uttenreuther-Fischer; Chuin-Sheng Huang; Ralph A. Reisfeld; Alice L. Yu

Book ID: 105309604
Publisher: Springer-Verlag
Year: 1995
Tongue: English
Weight: 823 KB
Volume: 41
Category: Article
ISSN: 0340-7004
DOI: 10.1007/bf01788957

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of human-mouse chimeric

Pharmacokinetics of human-mouse chimeric anti-GD2 mAb ch14.18 in a phase I trial in neuroblastoma patients

✍ M. M. Uttenreuther-Fischer; C. S. Huang; A. L. Yu 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 834 KB

A phase I study of neuroblastoma with th

A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a

✍ Rupert Handgretinger; Peter Baader; Roland Dopfer; Thomas Klingebiel; Peter Reul 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 835 KB

A Phase I/IB trial of murine monoclonal

A Phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma : A report of the Children's Cancer Group

✍ Jami D. Frost; Jacquelyn A. Hank; Gregory H. Reaman; Sharon Frierdich; Robert C. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Phase I/IB study of the Children's Cancer Group (CCG) and were monitored for toxicities and response

A phase I pharmacokinetic trial of zilas

A phase I pharmacokinetic trial of zilascorb(2H) in patients with advanced malignancies

✍ Semb, KA; Aamdal, S; Klem, B; Osmundsen, K; Bibow, K; Pronova, 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Re: A Phase 2 Cancer Chemoprevention Bio

Re: A Phase 2 Cancer Chemoprevention Biomarker Trial of Isoflavone G-2535 (Genistein) in Presurgical Bladder Cancer Patients

✍ Wood, David P. 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 104 KB

Phase I Trial of a Novel Anti-GD2 Monocl

Phase I Trial of a Novel Anti-GD2 Monoclonal Antibody, Hu14.18K322A, Designed to Decrease Toxicity in Children With Refractory or Recurrent Neuroblastoma

✍ Navid, F.; Sondel, P. M.; Barfield, R.; Shulkin, B. L.; Kaufman, R. A.; Allay, J 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 247 KB